Novel glucocorticoid receptor agonists

Details for Australian Patent Application No. 2008331187 (hide)

Owner Pfizer Limited

Inventors Millan, David Simon; Glossop, Paul Alan; Price, David Anthony

Agent Allens Arthur Robinson

Pub. Number AU-A-2008331187

PCT Pub. Number WO2009/069032

Priority 61/057,241 30.05.08 US; 60/991,354 30.11.07 US; 61/079,555 10.07.08 US

Filing date 17 November 2008

Wipo publication date 4 June 2009

International Classifications

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61P 5/46 (2006.01) Drugs for disorders of the endocrine system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

C07J 7/00 (2006.01) Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms

C07J 71/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton is condensed with a heterocyclic ring

Event Publications

20 May 2010 PCT application entered the National Phase

  PCT publication WO2009/069032 Priority application(s): WO2009/069032

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008331199-Pyrazole derivatives as 5-LO inhibitors

2008331168-Crystalline form I of lamivudine and its preparation